Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.46 USD | -6.51% | -14.21% | -37.34% |
05-13 | Morgan Stanley Lowers Price Target on NeuroPace to $9.50 From $13, Keeps Equalweight Rating | MT |
05-08 | NeuroPace, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-37.34% | 186M | |
+7.31% | 217B | |
+12.99% | 194B | |
+19.71% | 143B | |
+30.60% | 111B | |
+0.57% | 64.3B | |
+15.23% | 52.94B | |
+2.06% | 49.53B | |
-5.49% | 38.31B | |
-0.22% | 35.22B |
- Stock Market
- Equities
- NPCE Stock
- News NeuroPace, Inc.
- Transcript : NeuroPace, Inc., Q1 2024 Earnings Call, May 08, 2024